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In Taipei City, class suspensions were implemented be-
ginning September 1, 2009 when transmission of pandemic 
(H1N1) 2009 infection was suspected. The uptake rate of 
pandemic (H1N1) 2009 vaccination (starting on November 
16, 2009) among students 7–18 years of age was 74.7%. 
Outbreaks were mitigated after late November 2009.
A
s of April 25, 2010, >214 countries have reported lab-
oratory-conﬁ  rmed cases of pandemic (H1N1) 2009, 
including >17,919 deaths. Preparedness measures such as 
having substantial antiviral drug stockpiles for treatment 
and chemoprophylaxis and implementation of vaccination 
programs are considered crucial for effective control of the 
pandemic (1,2). In many countries, vaccination programs 
for pandemic (H1N1) 2009 were implemented by the end 
of 2009.
The US Centers for Disease Control and Prevention 
(CDC) recommends that nonpharmaceutical interventions 
should be implemented to reduce inﬂ  uenza transmission 
between persons after an outbreak and before vaccination 
programs begin (3). During the 1918–19 and 2009 inﬂ  uen-
za pandemics, class suspension and school closures, either 
reactively following outbreaks or proactively at a regional 
level, were implemented by many countries (4–8). CDC 
guidance suggests that during an inﬂ  uenza outbreak, poli-
cymakers should weigh the advantages and disadvantages 
of school closures before making a decision (9).
The Study
In Taiwan, persons were conﬁ  rmed to have pandemic 
(H1N1) 2009 infection if they had an acute febrile respi-
ratory illness with an epidemiologic link and a positive 
test  result for pandemic (H1N1) 2009. From June 1, 2009, 
through January 29, 2010, a total of 3,159 patients having 
documented pandemic (H1N1) 2009 infections were re-
ported to the Taiwan Centers for Disease Control (Taiwan 
CDC) (10). Of these patients, 887 (28.1%) were hospital-
ized and 39 (4.4%) died (Figure 1, panel A). In Taipei City, 
117 hospitalized patients infected with pandemic (H1N1) 
2009 virus were reported, and 4 patients (3.4%) died during 
the same period. Patients <18 years of age accounted for 
51.9% and 47.9% of all hospitalized patients in Taiwan and 
Taipei City, respectively (Figure 1, panel A) (10).
In Taiwan, a 2-3-5 intervention policy for class suspen-
sion was implemented beginning September 1 (week 35 of 
2009) for all students <18 years of age when transmission 
of inﬂ  uenza-like illness or inﬂ  uenza A/B virus infection 
(identiﬁ  ed by positive rapid antigen test [RAT] for inﬂ  u-
enza A/B) was suspected (11). Three commercial kits were 
available: QuickVue Inﬂ  uenza A+B (Quidel Corporation, 
San Diego, CA, USA), BD Directogen EZ Flu A+B (Bec-
ton Dickinson, Sparks, MD, USA), and BinaxNOW Inﬂ  u-
enza A&B (BinaxNOW, Portland, ME, USA) (11). Under 
the 2-3-5 policy, any class was suspended if >2 students 
were noted to have a positive RAT result or conﬁ  rmed 
pandemic (H1N1) 2009 within 3 days. Students from sus-
pended classes were asked to stay home for at least 5 days 
before returning to school. In addition, students’ tempera-
tures were checked at the entrance of each school during 
the pandemic; if any student’s temperature was >38oC, the 
student was suspended. 
Two pandemic (H1N1) 2009 vaccines were available: 
Focetria (Novartis, Basel, Switzerland, available since No-
vember 1, 2009) and AdimFlu-S (Adimmune Corporation, 
Taichung, Taiwan, available since November 16, 2009). 
Vaccination of front-line healthcare personnel began No-
vember 2, 2009; infants >6 months and <1 year received 
vaccine beginning November 11, 2009. Beginning No-
vember 16, 2009, pregnant women, preschool children 1–6 
years of age and students 7–12 years of age were vacci-
nated. Students 13–15 years of age (since November 23, 
2009) and 16–18 years of age (since November 30, 2009) 
(Figure 1, panel B), and persons with major illness or in-
jury were vaccinated simultaneously (10). For children 6 
months to 9 years of age, a second dose of vaccine was 
recommended with an interval of at least 3 weeks (10). For 
this age group, coverage rate of the vaccine in this report 
included those who had received at least 1 dose of vaccine. 
Immunization with pandemic (H1N1) 2009 vaccines was 
free and voluntary.
By January 29, 2010, less than half (5.6 million) of 
the planned doses (12 million) of pandemic (H1N1) 2009 
vaccine had been administered. The overall coverage of the 
vaccine in Taiwan (population ≈23 million) was ≈24.3%; 
the rate was 21.8% for Taipei City (population 2.6 million). 
Coverage rates of pandemic (H1N1) 2009 vaccine for dif-
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are shown in Figure 1, panel B. Overall, the coverage rate 
of the vaccine for school students 7–18 years of age was 
271,460/363,603 (74.7%) as of January 29, 2010. The cov-
erage rate for younger children (<6 years of age) and per-
sons 19–24 years of age was 30.3% (ﬁ  rst dose) and 3.1%, 
respectively (10).
As of January 29, 2010, a total of 1,708 classes in 
Taipei City’s elementary/primary, junior, and senior high 
schools had been suspended (Figure 2). The peak number 
of class suspensions (without school closures) occurred 
during September and November 2009, and no class was 
suspended after week 4 of 2010 (10). 
In Taipei City, a total of 171 hospitalized patients in-
fected with inﬂ  uenza viruses were identiﬁ  ed from June 1, 
2009, through January 29, 2010. These included 117 hospi-
talized patients infected with pandemic (H1N1) 2009 (Fig-
ure 2) (11). The pandemic (H1N1) 2009–related death rates 
were 1.54 and 1.78 per 1 million population in Taipei City 
and Taiwan, respectively; the death rate for Taiwan was 
the third lowest among the 32 members and observers of 
the Organization for Economic Cooperation and Develop-
ment (12). Three waves of inﬂ  uenza were identiﬁ  ed with 
activities that paralleled the intensity of class suspensions 
(Figure 2).
Conclusions
Although only about one ﬁ  fth of the population in 
Taipei City had received pandemic (H1N1) 2009 vaccina-
tion, the number of hospitalized patients with pandemic 
(H1N1) 2009 declined remarkably after mid-November 
to December 2009; no cases were reported after January 
29, 2010. The rationale of the 2-3-5 intervention policy 
in Taiwan was based on the incubation period of seasonal 
inﬂ  uenza. If inﬂ  uenza developed in 2 students in the same 
class within 3 days, it was anticipated that the virus had 
already been spread within the class. Because inﬂ  uenza 
virus shedding begins 24 hours before illness onset, we 
assumed that a 5-day observation period should detect all 
infected classmates.
The classroom structure in Taiwan’s middle schools 
and high schools is different from western countries and 
referred to as a “platoon” system. A group of students are 
placed together in a speciﬁ  c homeroom with a core teacher 
who also provides counseling to students and performs ad-
ministrative work. Other teachers who specialize in differ-
ent subjects move from class to class for teaching. The core 
teacher and administrative ofﬁ  cials can audit off-school ac-
tivities of each student through information technology.
Class suspensions or school closures alone may not be 
able to quell an epidemic, but these nonpharmaceutical in-
terventions may be able to provide additional time to prepare 
for vaccination (5–8). Children, especially older students in 
middle or high school, play a primary role in transmission 
of inﬂ  uenza within schools, families, and communities and 
should be a key target group for vaccination (11,13,14). In 
our study, the number of class suspensions also decreased 
concurrently with the declining trend of hospitalized patients 
with pandemic (H1N1) 2009. Implementation of a vacci-
nation policy for students, which began in mid-November 
(week 47), resulted in a remarkable decline of the third wave 
of pandemic (H1N1) 2009 two weeks later (week 49). This 
scenario suggests that the high vaccine coverage rate among 
students 6–18 years of age, as well as the 2-3-5 intervention 
policy, might have contributed to the rapid mitigation and 
subsequent cessation of the outbreak.
The results of our study demonstrate a more effective 
mitigation strategy to control inﬂ  uenza outbreaks during 
the wait for vaccines. Citywide class suspensions in Taipei 
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Figure 1. A) Incidence of hospitalization among patients infected 
with pandemic (H1N1) 2009 in each age group in Taipei City 
and throughout Taiwan as of week 4, 2010. B) Pandemic (H1N1) 
2009 vaccine coverage among persons <18 years of age by age 
group in Taipei City as of week 4, 2010 (from November 11, 2009, 
to January 29, 2010). Numbers within parentheses indicate the 
number of persons within each age group who were recommended 
for vaccination.Pandemic (H1N1) 2009, Taiwan
City and the high uptake rate of vaccination among stu-
dents may have had a combined effect in ending the inﬂ  u-
enza outbreaks.  
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Figure 2. Weekly number of class suspensions 
(including nursery schools, kindergartens, 
elementary/primary schools, and junior and 
senior high schools) and new hospitalized 
patients caused by pandemic (H1N1) 2009, 
conﬁ  rmed by real-time reverse transcription–
PCR in Taipei City, Taiwan, from week 29 in 
2009 to week 4 in 2010. W1–3, 3 waves of 
pandemic (H1N1) 2009 outbreaks. See text 
for details of the vaccination program for 
pandemic (H1N1) 2009 for school children 
7–18 years of age. 
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